Cambridge small molecule therapeutics firm FoldRx Pharmaceuticals Inc. is going to be acquired by pharmaceutical giant Pfizer Inc. as part of the latter company’s overall strategy to increase its pipeline of drugs to treat rare diseases.
<i>Tech across New England: </i>ProThera Biologics takes holistic approach to treating inflammationSeptember 1, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments
Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. ProThera Biologics develops technology centered on a protein in the blood that regulates the immune system and is the key to controlling sepsis...
In its latest move of adding or subtracting business lines, PerkinElmer Inc. reports it has agreed to sell its Illumination and Detection Solutions (IDS) business to Veritas Capital Fund III LP, a New York-based private equity firm, for approximately $500 million in cash.
InfoVue TFT LCDs come in both touch screen and standard formats and feature an extended temperature range, LED backlighting for high contrast, and a thin profile starting at an industry-leading 3.0 mm.
These custom die cut electrically insulated parts, that provide high dielectric strength, are flame retardant per UL94V-0 and are RoHS compliant.
BEI Kimco Magnetics, a company of Custom Sensors & Technologies (CST) Inc., has introduced the uniquely designed LA15-16-043Z voice coil actuator, featuring a large diameter clear aperture, compact size, and force high capabilities.
Low Installation Rates in Retail Pharmacies Across Europe Increase the Growth Potential of the Pharmacy Automation Systems Market, Finds Frost & SullivanSeptember 1, 2010 4:33 am | by Bio-Medicine.Org | News | Comments
LONDON, Sept. 1 /- The pharmacy automation systems market in Europe is experiencing a tremendous growth spurt. Until recently, most pharmacies have been either without automation or have employed very basic automation systems. In response, the adoption rate of automation systems across...
MEMPHIS, Tenn., Sept. 1 /PRNewswire-USNewswire/ -- Survival rates overall for childhood cancer are almost 80 percent—a marked advance against a disease that was curable in only a small fraction of children 50 years ago. However, despite progress, pediatric cancer remains the leading...
DUBLIN, Sep 01, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Wednesday, September 15, 2010. The event will be held at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY....
Inside: Read about low-volume layered manufacturing in “Parts Without Limits,” from Quickparts. Shared are professionals’ opinions on implantables and medical devices related to the military. Additionally, read about implantable cardiac devices, avoiding molding mishaps, disposables, and packaging and interconnects. Check out the selection of products, as well as the offerings for engineers in Design notes.
The diversified optical technologies company is expanding production of components used in new "gesture recognition" games consoles.
SCHOTT Solar and Solland Solar signed a partnership agreement that comprises technology license agreements, joint R&D efforts and joint production for back-contacted solar modules.
University of Florida researchers have helped to develop a device that quickly identifies genes and proteins in body fluids, a technique that could make a vital difference to the trauma patients doctors treat.
<i>Tech across New England: </i>Stromatec devices made to treat connective tissue problemsAugust 31, 2010 10:32 pm | by Mass High Tech: The Journal of New England Technology | News | Comments
Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. Stromatec specializes in medical devices that could help reduce health care costs by preventing unnecessary MRIs and even unnecessary surgery, by...
Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. EpiVax applies its tools to screening proteins for unwanted immune responses and using these tools to design and deimmunize protein therapeutics and vaccines.